Loading...

Regeneron Pharmaceuticals, Inc.

0R2M.L•LSE
Healthcare
Medical - Pharmaceuticals
£557.99
£11.31(2.07%)

Regeneron Pharmaceuticals, Inc. (0R2M.L) Stock Chart & Performance Analysis

Explore Regeneron Pharmaceuticals, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-4.57%
5-Day Change
-10.42%
1-Month Change
-26.41%
3-Month Change
-21.95%
6-Month Change
-45.53%
Year-to-Date (YTD) Change
-23.55%
1-Year Change
-41.59%
3-Year Change
-26.12%
5-Year Change
4.66%
All-Time (Max) Change
49.56%

Analyzing Regeneron Pharmaceuticals, Inc. (0R2M.L) Trends Across Multiple Time Frames

Regeneron Pharmaceuticals, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Regeneron Pharmaceuticals, Inc. stock shows -4.57% 1-day change, indicating low volatility, while its 5-day change of -10.42% suggests a broader trend. Over a 1-month period, a -26.41% drop could signal a pullback, whereas a 3-month decline of -21.95% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -45.53% and a YTD drop of -23.55% might concern investors, but a 1-year loss of -41.59% and a 3-year drop of -26.12% could indicate resilience. The 5-year surge of 4.66% highlights strong historical growth, while the all-time return of 49.56% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;